CN111700927A - Medicinal and edible composition with blood sugar reducing effect and preparation method and application thereof - Google Patents
Medicinal and edible composition with blood sugar reducing effect and preparation method and application thereof Download PDFInfo
- Publication number
- CN111700927A CN111700927A CN202010799647.0A CN202010799647A CN111700927A CN 111700927 A CN111700927 A CN 111700927A CN 202010799647 A CN202010799647 A CN 202010799647A CN 111700927 A CN111700927 A CN 111700927A
- Authority
- CN
- China
- Prior art keywords
- extract
- gynura procumbens
- lithocarpus litseifolius
- acid
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/49—Fagaceae (Beech family), e.g. oak or chestnut
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a medicinal and edible composition with the function of reducing blood sugar, a preparation method and application thereof, wherein the composition is prepared by mixing extracts of eucommia ulmoides, lithocarpus litseifolius and gynura procumbens, and the preparation method comprises the following steps: (1) drying, pulverizing and sieving Eucommiae cortex, Litsea Coreana Hayata and Gynura procumbens to obtain Eucommiae cortex, Litsea Coreana Hayata and Gynura procumbens powder; (2) respectively extracting the eucommia bark, lithocarpus litseifolius and gynura procumbens powder by using a solvent, precipitating with ethanol, extracting and crystallizing to obtain eucommia bark, lithocarpus litseifolius and gynura procumbens extracts; (3) mixing cortex Eucommiae, Lithocarpus litseifolius (wall.) Szel and Gynura procumbens (wall.) Druce extract at a ratio of 1:1:1-1:1:3, and shaking to obtain combined extract. The medicinal and edible composition produced by the invention can obviously reduce the blood glucose index and the postprandial blood glucose content of diabetics, has good prevention and treatment effects on complications caused by diabetes, and has obvious social and economic benefits.
Description
Technical Field
The invention belongs to the technical field of extraction and application of effective active ingredients of plants, and particularly relates to a medicinal and edible composition with a blood sugar reducing effect, and a preparation method and application thereof.
Background
Diabetes refers to a disease of glucose metabolism disorder caused by insufficient insulin secretion, insulin dysfunction, and glucose metabolism disorder, and its symptoms are polydipsia, polyphagia, polyuria, and weight loss. Diabetes is one of the biggest emergent health events in the world of the 21 st century, and the global prevalence rate is continuously rising, currently affecting 8.8% of adults. Diabetes can induce a variety of acute or chronic complications, such as cardiovascular and cerebrovascular diseases, diabetic nephropathy, and the like. The continuous disturbance of glycolipid metabolism can cause a plurality of diseases of large and small blood vessels, micro blood vessels, nerves and other systems, and cause the abnormality of tissue structure and function. Diabetes is known in the medical community as the "source of all diseases" and endangers the health of people in the world. Most of the medicines are chemically or biologically synthesized, so that the blood sugar reducing effect is obvious, but a lot of side effects are brought, and the expensive price is also forbidden. In recent years, research on extracting effective components from natural products for preventing and treating diabetes has become a hot spot. Therefore, it is a great development trend to find natural medicines and health foods with high efficiency, low toxicity and low price from the Chinese medicines with abundant resources.
The botanical name of the Gynura procumbens (Gynura procumbens (Lour.) Merr.) is that the Gynura plant is a plant of Compositae, and also is a plant of the genus Panax, namely a Chinese-senna, a senecio and a Shenxiancao, which is pungent, slightly bitter and cool in nature, is a perennial herbal medicine and food dual-purpose plant and is widely distributed in China, Malaysia, Thailand, Indonesia, Korea, Philippine and other countries. Gynura procumbens has wide pharmacological effects, in the first half of 2009, toxicology inspection, hygiene inspection and inspection of various components are completed by relevant units such as the Chinese disease prevention and control center, the national food quality supervision and inspection center, the Chinese food fermentation industry research institute and the like, and the conclusion is that: no toxicity and no teratogenic influence; the effective components of the medicine have the effects of clearing and activating the channels and collaterals, diminishing inflammation and relieving cough, dissipating blood stasis and reducing swelling, promoting blood circulation and promoting tissue regeneration, treating traumatic injury, bronchopneumonia, phthisis and the like; can delay aging, activate immunocyte, improve organism immunity, enhance metabolism and improve dysmnesia; has the obvious effects of reducing blood pressure, blood fat and blood sugar, resisting oxidation and ulcer, preventing chronic nephropathy and inhibiting hepatitis B; has certain curative effect on preventing and treating cardiovascular and cerebrovascular diseases, diabetes and the like; it also has antiviral, antibacterial, and bone marrow cancer and shiga-like toxin cell inhibiting effects. On the other hand, gynura procumbens is a unique plant which can be used as both medicine and food and has extremely good nutritional value, so that the gynura procumbens is widely applied to the fields of food and medicine industry, daily chemical industry and the like and is a plant which can be used as both medicine and food and has extremely high potential and high economic value.
Lithocarpus litseifolius (Lithocarpus polystachyus Rehd), Lithocarpus polystachyus, Rubus suavissimus, and Lithocarpus polystachyus. The wild state is mostly distributed in the provinces of south of the Yangtze river, and the resources of Jiangxi, Hunan, Fujian, Guangxi, Anhui and other provinces are most concentrated. Phlorizin and trilobatin are used as main components, and the content is up to 9.0-14.60%. Modern medical research shows that Lithocarpus litseifolius has effects of clearing heat, promoting diuresis, moistening lung, relieving cough, nourishing liver and kidney, etc., can be used for preventing and treating warm dysentery, carbuncle, malignant boil, skin pruritus, etc., and also has effects of 'three resisting' and 'three reducing'. Modern researches show that Lithocarpus litseifolius has pharmacological effects of resisting oxidation, reducing blood sugar, reducing blood lipid, resisting bacteria, resisting inflammation, resisting allergy, etc.
Eucommia ulmoides (Eucommia ulmoides Oliver), also known as Bakelite, is a plant of genus Eucommia of family Eucommiaceae. The eucommia ulmoides oliv extract is a unique and precious nourishing traditional Chinese medicinal material in China, has high medicinal value, and has the effects of resisting aging, resisting oxidation, reducing blood pressure, reducing blood fat, reducing blood sugar, resisting mutagenesis, resisting cancer, resisting bacteria, resisting viruses and the like according to modern pharmacological research. The eucommia ulmoides has rich active ingredients, mainly contains flavonoids, phenylpropanoids, iridoids, polysaccharides, polyphenols, phenylpropanoids, lignans and the like, has outstanding pharmacological action of the eucommia ulmoides, and has various health-care effects. Eucommia bark is treasure throughout the body, and its seeds, flowers, bark and leaves can be eaten. Through toxicological identification, the eucommia seed oil and the eucommia male flowers are safe and non-toxic, the eucommia seed oil and the eucommia male flowers are approved as new food raw materials by the national health committee, and the eucommia leaves are also approved by the national health committee in 2019 to be listed in a human and food homology test list, so that the eucommia leaf tea has a great prospect in the aspect of health food development.
Disclosure of Invention
The invention aims to provide a medicinal and edible composition with a hypoglycemic effect and a preparation method and application thereof, wherein different extraction and purification modes are utilized to respectively enrich effective components in eucommia ulmoides, lithocarpus litseifolius and gynura procumbens, the obtained powders are combined in an optimized combination mode, and the hypoglycemic activity test is carried out on the composition.
In order to achieve the purpose, the invention adopts the following technical scheme:
a medicine-food homologous composition with a blood sugar reducing effect is prepared by respectively taking eucommia ulmoides, lithocarpus litseifolius and gynura procumbens as raw materials, respectively extracting an eucommia ulmoides extract, a lithocarpus litseifolius extract and a gynura procumbens extract, and then mixing the eucommia ulmoides extract, the lithocarpus litseifolius extract and the gynura procumbens extract according to a mass ratio of 1:1:1-1:1:3 to obtain a combined extract.
Further preferably, the combined extract contains chlorogenic acid, cryptochlorogenic acid, caffeic acid, geniposide, asperuloside, isochlorogenic acid B, catechin, isoquercitrin, isochlorogenic acid A, phlorizin, pinoresinol diglucoside, isochlorogenic acid C, trilobatin and rutin.
A preparation method of a medicinal and edible composition with a hypoglycemic effect comprises the following steps:
step 1): collecting folium Eucommiae as raw material, drying, pulverizing, extracting with water at 80 deg.C at a ratio of 1:10-20 under stirring, filtering, mixing filtrates, concentrating under reduced pressure to 1/10 of the stock solution, adding 4 times of anhydrous ethanol, placing in refrigerator, standing overnight, centrifuging, collecting supernatant, concentrating to no ethanol smell, adding equal amount of distilled water, ultrasonic pulverizing, extracting with solvent of the same volume for three times, mixing extractive phases, and concentrating to dry to obtain folium Eucommiae extract;
step 2): collecting Lithocarpus litseifolius leaves as raw materials, drying, pulverizing, extracting with water at 70 deg.C at a ratio of 1:10-20 under stirring, filtering, mixing filtrates, concentrating under reduced pressure to 1/10 of stock solution, adding 10% active carbon, stirring at 70 deg.C for decolorizing, and spray drying the filtrate to obtain Lithocarpus litseifolius extract;
step 3): collecting folium Notoginseng of Gynura procumbens as raw material, drying, pulverizing, extracting with ethanol water solution, centrifuging, collecting supernatant, concentrating until no alcohol smell is present, and concentrating until dry to obtain folium Notoginseng extract of Gynura procumbens;
step 4): mixing Eucommiae cortex extract, Lithocarpus litseifolius extract and Gynura procumbens extract at a certain proportion, and shaking to obtain medicinal and edible composition.
Further, in the step 4), the eucommia ulmoides extract, the lithocarpus litseifolius extract and the gynura procumbens extract are mixed according to the mass ratio of 1:1:1-1:1:3 to obtain the combined extract.
Further, the combined extract needs to contain chlorogenic acid, cryptochlorogenic acid, caffeic acid, geniposide, asperuloside, isochlorogenic acid B, catechin, isoquercitrin, isochlorogenic acid A, phlorizin, pinoresinol diglucoside, isochlorogenic acid C, trilobatin, rutin and other components.
Further, in the step 3), the extraction solvent is 50-90% ethanol water solution with pH of 2-7, the liquid-material ratio is 1:10-20, the extraction temperature is normal temperature, ultrasonic extraction is carried out for 2 hours, and the filtrate is concentrated under reduced pressure until no alcohol smell exists.
Further, the organic solvent used in step 1) is any one of petroleum ether, n-hexane, dichloromethane, ethyl acetate, n-butanol, dichloromethane/methanol and petroleum ether/ethyl acetate.
Further, preferably, the extraction solvent used in step 1), the selected extraction solvent is ethyl acetate/methanol, and the volume ratio of ethyl acetate/methanol is 4: 1.
The invention also provides application of the prepared medicinal and edible composition in preparing a diabetes medicament.
Due to the adoption of the technical scheme, the invention has the following advantages:
the invention enriches the effective components of eucommia bark, lithocarpus litseifolius and gynura procumbens by different extraction and purification modes to obtain 14 effective components which are respectively chlorogenic acid, cryptochlorogenic acid, caffeic acid, geniposide, asperuloside, isochlorogenic acid B, catechin, isoquercitrin, isochlorogenic acid A, phlorizin, pinoresinol diglucoside, isochlorogenic acid C, trilobatin and rutin, wherein the content of the chlorogenic acid A, the phlorizin, the pinoresinol diglucoside, the isochlorogenic acid C, the trilobatin and the rutin account for 90 percent of the powder of the composition, thereby disclosing the material basis for reducing blood sugar. The prepared medicinal and edible composition has a particularly good effect on patients with diabetes, gout of patients who use the extract is not recurrent basically, and the effect is obviously better than that of the extracts of eucommia ulmoides, lithocarpus litseifolius and gynura procumbens which are used independently.
Drawings
FIG. 1 is a liquid chromatogram of a composition of the invention.
FIG. 2 is a liquid chromatogram of the Gynura procumbens extract of the present invention.
FIG. 3 is a liquid chromatogram of an extract of eucommia ulmoides Oliver according to the present invention.
FIG. 4 is a liquid chromatogram of the Lithocarpus litseifolius extract of the present invention.
FIG. 5 is a liquid chromatogram of a comparative example extract of the present invention.
Detailed Description
The present invention will be further described in detail with reference to the following examples; however, the following examples are merely illustrative, and the present invention is not limited to these examples.
A preparation method of a medicinal and edible composition with a hypoglycemic effect comprises the following steps:
step 1): collecting folium Eucommiae as raw material, drying, pulverizing, extracting with water at 80 deg.C at a ratio of 1:10-20 under stirring, filtering, mixing filtrates, concentrating under reduced pressure to 1/10 of the stock solution, adding 4 times of anhydrous ethanol, placing in refrigerator, standing overnight, centrifuging, collecting supernatant, concentrating to no ethanol smell, adding equal amount of distilled water, ultrasonic pulverizing, extracting with solvent of the same volume for three times, mixing extractive phases, and concentrating to dry to obtain folium Eucommiae extract;
step 2): collecting Lithocarpus litseifolius leaves as raw materials, drying, pulverizing, extracting with water at 70 deg.C at a ratio of 1:10-20 under stirring, filtering, mixing filtrates, concentrating under reduced pressure to 1/10 of stock solution, adding 10% active carbon, stirring at 70 deg.C for decolorizing, and spray drying the filtrate to obtain Lithocarpus litseifolius extract;
step 3): collecting Notoginseng radix of Gynura procumbens as raw material, drying, pulverizing, extracting with ethanol water as extraction solvent, centrifuging, collecting supernatant, concentrating until no ethanol smell is present, and concentrating until dry to obtain Notoginseng radix extract of Gynura procumbens;
step 4): mixing Eucommiae cortex extract, Lithocarpus litseifolius extract and Gynura procumbens extract at a certain proportion, and shaking to obtain medicinal and edible composition. The combined extract contains chlorogenic acid, cryptochlorogenic acid, caffeic acid, geniposide, asperuloside, isochlorogenic acid B, catechin, isoquercitrin, isochlorogenic acid A, phlorizin, pinoresinol diglucoside, isochlorogenic acid C, trilobatin and rutin by liquid phase detection.
Example 1
Taking 100g of eucommia ulmoides leaves, drying and crushing the eucommia ulmoides leaves, adopting water as an extraction solvent, extracting at the temperature of 80 ℃ and the material-liquid ratio of 1:20, stirring and extracting, filtering, combining filtrate, concentrating the filtrate under reduced pressure to 1/10 of stock solution, adding 4 times of absolute ethyl alcohol, putting the mixture into a refrigerator, standing overnight, centrifuging, collecting supernatant, concentrating the supernatant until no alcohol smell exists, adding equal amount of distilled water for ultrasonic wave scattering, adding equal volume of n-butyl alcohol for extraction, extracting for three times, combining extraction phases, concentrating until the eucommia ulmoides leaves are dried to prepare 2.35g of eucommia ulmoides leaf extract, wherein the yield is 2.35%, and the liquid chromatogram of the eucommia ulmoides extract is shown in.
Taking 100g of Lithocarpus litseifolius, drying, crushing, taking water as an extraction solvent, extracting at 70 ℃ under stirring with a material-liquid ratio of 1:20, filtering, combining filtrates, concentrating under reduced pressure to 1/10 of a stock solution, adding 10% of active carbon, stirring at 70 ℃ for decolorization, and spray-drying the filtrate to obtain 6.42g of Lithocarpus litseifolius extract with the yield of 6.42%, wherein a liquid chromatogram of the Lithocarpus litseifolius extract is shown in FIG. 4.
Taking 100g of gynura procumbens leaf, drying and crushing the gynura procumbens leaf, adopting 50% ethanol water solution with pH of 3, wherein the material-liquid ratio is 1:10, the extraction temperature is normal temperature, carrying out ultrasonic extraction for 2 hours, and carrying out reduced pressure concentration on the filtrate until no alcohol smell exists. Concentrating to dry to obtain Gynura procumbens leaf extract 9.24g, with yield 9.24%, and liquid chromatogram of Gynura procumbens extract shown in figure 2.
Mixing the eucommia ulmoides extract, the lithocarpus litseifolius extract and the gynura procumbens extract according to the mass ratio of 1:1:1, and shaking uniformly to prepare the medicine-food homologous composition. The combined extract contains 1 chlorogenic acid, 2 cryptochlorogenic acid, 3 caffeic acid, 4 geniposide, 5 asperuloside, 6 isochlorogenic acid B, 7 catechin, 8 isoquercitrin, 9 isochlorogenic acid A, 10 phloridzin, 11 pinoresinol diglucoside, 12 isochlorogenic acid C, 13 trilobatin and 14 rutin by liquid phase detection, as shown in figure 1.
Example 2
Taking 100g of eucommia ulmoides leaves, drying and crushing the eucommia ulmoides leaves, adopting water as an extraction solvent, stirring and extracting the eucommia ulmoides leaves at the extraction temperature of 80 ℃ and the material-liquid ratio of 1:10, filtering, combining filtrate, concentrating the filtrate under reduced pressure to 1/10 of stock solution, adding 4 times of absolute ethyl alcohol, putting the mixture into a refrigerator, standing overnight, centrifuging, collecting supernatant, concentrating the supernatant until no alcohol smell exists, adding equal amount of distilled water, performing ultrasonic wave scattering, adding equal volume of dichloromethane/methanol for extraction, extracting the mixture for three times, combining extract phases, and concentrating the extract phases until the extract is dried to obtain 4.18g of eucommia ulmoides leaf extract, wherein the yield is 4.;
taking 100g of lithocarpus litseifolius, drying, crushing, taking water as an extraction solvent, extracting at 70 ℃ with a material-liquid ratio of 1:10 under stirring, filtering, combining the filtrates, concentrating under reduced pressure to 1/10 of the stock solution, adding 10% of activated carbon, stirring and decolorizing at 70 ℃, and spray drying the filtrate to obtain 4.25g of lithocarpus litseifolius extract with the yield of 4.25%.
Taking 100g of gynura procumbens leaf, drying and crushing the gynura procumbens leaf, adopting 80% ethanol water solution with the pH value of 2, the material-liquid ratio is 1:20, extracting at the normal temperature, carrying out ultrasonic extraction for 2 hours, and concentrating the filtrate under reduced pressure until no alcohol smell exists. Concentrating to dry to obtain Gynura procumbens leaf extract 8.77g, with yield 8.77%.
Mixing the eucommia ulmoides extract, the lithocarpus litseifolius extract and the gynura procumbens extract according to the mass ratio of 1:1:2, and shaking uniformly to prepare the medicine-food homologous composition. The combined extract contains chlorogenic acid, cryptochlorogenic acid, caffeic acid, geniposide, asperuloside, isochlorogenic acid B, catechin, isoquercitrin, isochlorogenic acid A, phlorizin, pinoresinol diglucoside, isochlorogenic acid C, trilobatin and rutin by liquid phase detection.
Example 3
Taking 100g of eucommia ulmoides leaves, drying and crushing the eucommia ulmoides leaves, adopting water as an extraction solvent, carrying out extraction at 80 ℃ and a material-liquid ratio of 1:15, stirring and extracting, filtering, combining filtrate, concentrating the filtrate under reduced pressure to 1/10 of stock solution, adding 4 times of absolute ethyl alcohol, putting the mixture into a refrigerator, standing overnight, centrifuging, collecting supernatant, concentrating the supernatant until no alcohol smell exists, adding equal amount of distilled water, carrying out ultrasonic wave scattering, adding equal volume of petroleum ether/ethyl acetate for extraction, carrying out extraction for three times, combining extract phases, and concentrating until the mixture is dried to obtain 2.04g of eucommia ulmoides leaf extract, wherein the yield is 2.04%.
Taking 100g of Lithocarpus litseifolius, drying, crushing, taking water as an extraction solvent, extracting at 70 ℃ with stirring, wherein the material-liquid ratio is 1:15, filtering, combining the filtrates, concentrating under reduced pressure to 1/10 of the stock solution, adding 10% of active carbon, stirring and decolorizing at 70 ℃, and spray drying the filtrate to obtain 7.44g of Lithocarpus litseifolius extract with the yield of 7.44%.
Taking 100g of gynura procumbens leaf, drying and crushing the gynura procumbens leaf, extracting the gynura procumbens leaf by using 60% ethanol water with pH value of 7 at a material-liquid ratio of 1:15 at normal temperature under ultrasonic waves for 2 hours, and concentrating the filtrate under reduced pressure until no alcohol smell exists. Concentrating to dry and obtaining the gynura procumbens pseudo-ginseng leaf extract 10.45g with the yield of 10.45 percent.
Mixing the eucommia ulmoides extract, the lithocarpus litseifolius extract and the gynura procumbens extract according to the mass ratio of 1:1:3, and shaking uniformly to prepare the medicine-food homologous composition. The combined extract contains chlorogenic acid, cryptochlorogenic acid, caffeic acid, geniposide, asperuloside, isochlorogenic acid B, catechin, isoquercitrin, isochlorogenic acid A, phlorizin, pinoresinol diglucoside, isochlorogenic acid C, trilobatin and rutin by liquid phase detection.
Comparative example
Taking 100g of each of eucommia ulmoides leaves, lithocarpus litseifolius and gynura procumbens, crushing the materials by using a crusher, adding the crushed materials into a conical flask, extracting by using 90% ethanol water solution with the pH value of 5 at the material-liquid ratio of 1:15 at the normal temperature for 2 hours by ultrasonic extraction, filtering, and concentrating the filtrate under reduced pressure until no alcohol smell exists. Adding 100% ethanol solution 4 times the volume of the obtained solution, placing in a refrigerator at 4 deg.C overnight for alcohol precipitation, centrifuging, collecting supernatant, concentrating under reduced pressure until no alcohol smell exists to obtain mixed extractive solution, extracting the mixed extractive solution with solvent of n-butanol, mixing extractive solutions, concentrating under reduced pressure, and drying to obtain mixed extract 4.52g containing chlorogenic acid, isochlorogenic acid B, isochlorogenic acid A, phlorizin, isochlorogenic acid C and rutin. The compounds of cryptochlorogenic acid, caffeic acid, geniposide, asperuloside, catechin, isoquercitrin, pinoresinol diglucoside and trilobatin were not detected.
Influence of medicinal and edible composition on mouse blood sugar caused by streptozotocin
130 healthy male Kunming mice (about 20g) were selected as experimental animals and randomly divided into 13 groups of 10 groups of (blank control group, model control group, positive control group (acarbose), mixed extract group of 1:1:1 high dose group, mixed extract group of 1:1:1 low dose group, mixed extract group of 1:1:2 high dose group, mixed extract group of 1:1:2 low dose group, mixed extract group of 1:1:3 high dose group, mixed extract group of 1:1:3 low dose group, Lithocarpus litseifolius extract group, Gynura procumbens extract group, eucommia ulmoides leaf extract group, comparative example group). In the first week, the common feed is selected to provide sufficient food and water so as to avoid the abnormality caused by environmental change. One week later, all mice began a quick water feeding, and 12 hours later, the blank control group was injected with 0.1mol/L of STZ solution intraperitoneally. The injection dose per mouse was selected at 60mg/kg to model type 2 diabetes, and the blank control group was injected with an equal volume of distilled water. After injection, the placebo mice were fed normal diet and the remaining mice were fed high sugar and high fat diets for 5 days. After 5 days of modeling, mice were tested for blood glucose, which ranged from 11-25mmol/L and was considered successful. If mice with blood glucose values of less than 11mmol/L are present, additional injections of STZ are required, which are dissolved in citrate buffer at a pH between 4.2 and 4.5. And stored in test tubes wrapped in foil. And injected rapidly into the abdominal cavity of the mice during 30 min. Data results are expressed as mean ± standard deviation (x ± s), and differences between groups are analyzed by one-way variance analysis through statistical software package SPSS 19.0 version, where P <0.05 is considered significant difference and P >0.05 is not significant difference.
The mice with blood sugar concentration within 11-25mmol/L after molding are evenly distributed into 13 groups according to body weight and blood sugar concentration respectively, and the gavage is carried out according to the table 1.
TABLE 1 animal Experimental groups
As shown in table 2, it can be seen from the table that fasting blood glucose levels of diabetic mice significantly increased after successful modeling. And maintained high blood glucose levels, with very significant differences (p <0.01) compared to the blank control group, STZ successfully induced and mimicked the hyperglycemic model of mouse diabetes. The mean blood glucose levels of the blank control group stabilized at 5mmol/L throughout the dosing period, while the mice of the model control group gradually increased with the dosing period. Indicating that the diabetic condition is gradually serious until the fourth and fifth weeks are kept at about 25mmol/L, and the difference between the composition and the low and high dose groups is significant or extremely significant (P <0.01 or P < 0.05).
In the positive control group and mixed extract 1:1:1 high dose group, mixed extract ═ 1:1:1 low dose group, mixed extract ═ 1:1:2 high dose group, mixed extract ═ 1:1:2 low dose group, mixed extract ═ 1:1:3 high dose group, mixed extract ═ 1:1: in the 3 low dose group, the blood glucose levels in the first three weeks of mice increased with increasing treatment period. However, it was slower than the model control group. From week 4, the positive control group significantly reduced fasting blood glucose levels in diabetic mice; after five weeks of gastric lavage, the blood sugar of the positive control group mice is reduced by 45.54 percent compared with the blood sugar of the model control group mice, and the significant difference exists.
Mixed extract 1:1:1 high dose group, mixed extract ═ 1:1:2 high dose group, mixed extract ═ 1:1: the fasting blood sugar values of the mice in the 3 high-dose groups are reduced in different degrees from the fourth week of the gavage, and show a significant or very significant difference compared with the model control group ((P <0.01 or P <0.05), after 5 weeks of the gavage, the blood sugar of the mice in the mixed extract 1:1:1 high-dose group, the blood sugar of the mice in the mixed extract 1:1:2 high-dose group and the blood sugar of the mice in the mixed extract 1:1:3 high-dose group are reduced by 80 percent on average relative to the blood sugar of the mice in the model group, and the possibility of controlling the diabetes by the composition can be proved.
The lithocarpus litseifolius extract group, the gynura procumbens extract group and the eucommia ulmoides leaf extract group show the same trend in fasting blood glucose value of mice in the comparative example group and the high and low dose groups of the mixed extract, except that the lithocarpus litseifolius extract group, the gynura procumbens extract group and the eucommia ulmoides leaf extract group show poorer effects in the fourth and fifth weeks than the mixed extract group, but the lithocarpus litseifolius extract group, the gynura procumbens extract group and the eucommia ulmoides leaf extract group have smaller fasting blood glucose values in the fourth and fifth weeks than the comparative example group, which indicates that the mixed extract effect is better than that of the extracts of the three independent medicinal and edible plants under the same dose and the comparative example has the worst effect.
TABLE 2 Effect of Mixed extracts on blood glucose levels in diabetic mice
Compared with the normal control group, the composition has the advantages that,##P<0.01; in comparison to the set of models,*P<0.05,**P<0.01 and***P<0.001。
the above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents and improvements made within the spirit and principle of the present invention are intended to be included within the scope of the present invention.
Claims (8)
1. A medicine-food homologous composition with a hypoglycemic effect and a preparation method and application thereof are characterized in that: the composition is prepared by respectively taking eucommia ulmoides, lithocarpus litseifolius and gynura procumbens as raw materials, respectively extracting an eucommia ulmoides extract, a lithocarpus litseifolius extract and a gynura procumbens extract, and then mixing the eucommia ulmoides extract, the lithocarpus litseifolius extract and the gynura procumbens extract according to the proportion of 1:1:1-1:1:3 to obtain a combined extract.
2. The medicine-food homologous composition with the hypoglycemic effect as claimed in claim 1, and the preparation method and the application thereof are characterized in that: the combined extract contains 1 chlorogenic acid, 2 cryptochlorogenic acid, 3 caffeic acid, 4 geniposide, 5 asperuloside, 6 isochlorogenic acid B, 7 catechin, 8 isoquercitrin, 9 isochlorogenic acid A, 10 phloridzin, 11 pinoresinol diglucoside, 12 isochlorogenic acid C, 13 trilobatin and 14 rutin.
3. A medicine-food homologous composition with a hypoglycemic effect and a preparation method and application thereof are characterized by comprising the following steps:
step 1): collecting folium Eucommiae as raw material, drying, pulverizing, extracting with water at 80 deg.C at a liquid-to-material ratio of 1:10-20 under stirring, filtering, mixing filtrates, concentrating under reduced pressure to 1/10 of the stock solution, adding 4 times of anhydrous ethanol, placing in refrigerator, standing overnight, centrifuging, collecting supernatant, concentrating to no alcohol smell, adding equal amount of distilled water, ultrasonic pulverizing, adding equal volume of solvent, extracting for three times, mixing extractive phases, and concentrating to dry to obtain folium Eucommiae extract;
step 2): collecting Lithocarpus litseifolius leaves as raw materials, drying, pulverizing, extracting with water at 70 deg.C at a liquid-to-material ratio of 1:10-20 under stirring, filtering, mixing filtrates, concentrating under reduced pressure to 1/10 of the stock solution, adding 10% active carbon, stirring at 70 deg.C for decolorizing, and spray drying the filtrate to obtain Lithocarpus litseifolius extract;
step 3): collecting Notoginseng radix of Gynura procumbens as raw material, drying, pulverizing, extracting with ethanol water as extraction solvent, centrifuging, collecting supernatant, concentrating until no ethanol smell is present, and concentrating until dry to obtain Notoginseng radix extract of Gynura procumbens;
step 4): mixing Eucommiae cortex extract, Lithocarpus litseifolius extract and Gynura procumbens extract at a certain proportion, and shaking to obtain medicinal and edible composition.
4. The medicine-food homologous composition with the blood sugar reducing effect as claimed in claim 1, and the preparation method and the application thereof, are characterized in that in the step 4), the eucommia ulmoides extract, the lithocarpus litseifolius extract and the gynura procumbens extract are mixed according to the ratio of 1:1:1-1:1:3 to obtain the combined extract.
5. The composition as claimed in claim 1, wherein the combined extract contains 1 chlorogenic acid, 2 cryptochlorogenic acid, 3 caffeic acid, 4 geniposide, 5 asperuloside, 6 isochlorogenic acid B, 7 catechin, 8 isoquercitrin, 9 isochlorogenic acid A, 10 phlorizin, 11 pinoresinol diglucoside, 12 isochlorogenic acid C, 13 trilobatin and 14 rutin.
6. The medicinal and edible composition with the hypoglycemic effect as claimed in claim 1, and the preparation method and the application thereof, wherein in step 3), the extraction solvent is 50-90% ethanol aqueous solution with pH of 2-7, the liquid-material ratio is 1:10-20, the extraction temperature is normal temperature and ultrasonic extraction is performed for 2 hours, and the filtrate is concentrated under reduced pressure until no alcohol smell exists.
7. The medicine-food homologous composition with the hypoglycemic effect as claimed in claim 1, and the preparation method and the application thereof, wherein the organic solvent used in step 1) is any one of petroleum ether, n-hexane, dichloromethane, ethyl acetate, n-butanol, dichloromethane/methanol, and petroleum ether/ethyl acetate.
8. Use of the medicinal and edible composition prepared according to any one of claims 1-7 in preparation of a medicament for treating diabetes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010799647.0A CN111700927B (en) | 2020-08-11 | 2020-08-11 | Medicinal and edible composition with blood sugar reducing effect and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010799647.0A CN111700927B (en) | 2020-08-11 | 2020-08-11 | Medicinal and edible composition with blood sugar reducing effect and preparation method and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111700927A true CN111700927A (en) | 2020-09-25 |
| CN111700927B CN111700927B (en) | 2021-07-30 |
Family
ID=72547105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010799647.0A Active CN111700927B (en) | 2020-08-11 | 2020-08-11 | Medicinal and edible composition with blood sugar reducing effect and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111700927B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112843009A (en) * | 2021-03-26 | 2021-05-28 | 广西壮族自治区林业科学研究院 | Method for preparing phlorizin mixed hypoglycemic preparation |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101260131A (en) * | 2008-04-19 | 2008-09-10 | 吉首大学 | Method for extracting iridoid active site and monomer from eucommia bark |
| CN101602668A (en) * | 2009-07-13 | 2009-12-16 | 江西省科学院应用化学研究所 | The method that a kind of chlorogenic acid extracts |
| CN101904882A (en) * | 2010-07-28 | 2010-12-08 | 广西壮族自治区中医药研究院 | Preparation method of lithocarpus litseifolius total flavone |
| CN102670696B (en) * | 2012-05-03 | 2014-04-16 | 中国药科大学 | Eucommia ulmoids leaf extracts and preparation method and application thereof |
| CN108689852A (en) * | 2018-06-26 | 2018-10-23 | 江西省科学院应用化学研究所 | A method of chlorogenic acid extracting and isochlorogenic acid from Gynura procumbens (Lour.) Merr |
| CN110893197A (en) * | 2019-12-05 | 2020-03-20 | 江西省科学院应用化学研究所 | Panax notoginseng extract for treating gout and preparation method thereof |
| CN111281902A (en) * | 2018-12-06 | 2020-06-16 | 常州高新技术产业开发区三维工业技术研究所有限公司 | Application of lithocarpus litseifolius or active extract thereof |
-
2020
- 2020-08-11 CN CN202010799647.0A patent/CN111700927B/en active Active
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101260131A (en) * | 2008-04-19 | 2008-09-10 | 吉首大学 | Method for extracting iridoid active site and monomer from eucommia bark |
| CN101602668A (en) * | 2009-07-13 | 2009-12-16 | 江西省科学院应用化学研究所 | The method that a kind of chlorogenic acid extracts |
| CN101904882A (en) * | 2010-07-28 | 2010-12-08 | 广西壮族自治区中医药研究院 | Preparation method of lithocarpus litseifolius total flavone |
| CN102670696B (en) * | 2012-05-03 | 2014-04-16 | 中国药科大学 | Eucommia ulmoids leaf extracts and preparation method and application thereof |
| CN108689852A (en) * | 2018-06-26 | 2018-10-23 | 江西省科学院应用化学研究所 | A method of chlorogenic acid extracting and isochlorogenic acid from Gynura procumbens (Lour.) Merr |
| CN111281902A (en) * | 2018-12-06 | 2020-06-16 | 常州高新技术产业开发区三维工业技术研究所有限公司 | Application of lithocarpus litseifolius or active extract thereof |
| CN110893197A (en) * | 2019-12-05 | 2020-03-20 | 江西省科学院应用化学研究所 | Panax notoginseng extract for treating gout and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 倪青主编: "《糖尿病中医循证治疗学》", 31 May 2015, 科学技术文献出版社 * |
| 王娟娟 等: "杜仲化学成分、药理活性和质量控制现状研究进展", 《中草药》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112843009A (en) * | 2021-03-26 | 2021-05-28 | 广西壮族自治区林业科学研究院 | Method for preparing phlorizin mixed hypoglycemic preparation |
| CN112843009B (en) * | 2021-03-26 | 2022-08-05 | 广西壮族自治区林业科学研究院 | Method for preparing phlorizin mixed hypoglycemic preparation |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111700927B (en) | 2021-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103230473B (en) | Lycium ruthenicum Murr. effective extract, extracting method and extract are applied | |
| CN111840363B (en) | Natto-assisted hypoglycemic health-care composition and preparation method and application thereof | |
| CN101007017B (en) | Extract of traditional Chinese medicine having alpha-glucosidase inhibitor activity and its application | |
| CN108904563B (en) | Processing method and application of whole-plant ginseng raw stock | |
| CN103768152A (en) | Osmanthus phenylethanoid glycoside extract, and preparation method and application thereof | |
| CN110893197B (en) | Panax notoginseng extract for treating gout and preparation method thereof | |
| CN101401829A (en) | Wild Jinchai liveness extract, preparation and uses thereof | |
| CN104982597B (en) | A kind of multi-functional composite instant tea and its preparation method and application | |
| CN111700927B (en) | Medicinal and edible composition with blood sugar reducing effect and preparation method and application thereof | |
| CN108813501A (en) | With the relieving cough and reducing sputum health honey paste relievingd asthma and adjust function of human body of clearing heat and moistening lung | |
| CN103734767A (en) | Health-care food | |
| CN110140812A (en) | Prawn Chinese herbal medicine immunopotentiator and preparation method thereof | |
| CN109674848A (en) | A kind of preparation method and purposes of licorice | |
| CN101248877A (en) | Anti-senescence functional food product and method for preparing the same | |
| CN101199652B (en) | Medicament for treating acute, subacute eczema and preparing method thereof | |
| CN1943448A (en) | Bamboo juice and ginkgo drink and its producing method | |
| CN108685964B (en) | Application of gerbera piloselloides extract and preparation method of active ingredients of gerbera piloselloides extract | |
| CN106937718A (en) | A kind of pair of marine alga pollen plant composite beverage and preparation method thereof | |
| CN105796656A (en) | Cistanche tubulosa extract and preparation method thereof | |
| CN111887367A (en) | Loquat flower beverage and preparation method thereof | |
| CN110679818A (en) | Multifunctional shepherd's purse water extract solid beverage and preparation method thereof | |
| CN114507297B (en) | Preparation and application of polysaccharide extract of birch mushroom | |
| CN109528857A (en) | A kind of campanulaceae particle and preparation method thereof for treating respiratory disease caused by haze | |
| CN101584719B (en) | Application of acanthopanax fruit extractive in preparing medicament for treating hyperlipoidemia | |
| CN102558249A (en) | Salvia miltiorrhiza stachyose, and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20210918 Address after: 330200 Room 303, third floor, South Building, apartment in evergreen science and Technology Park, No. 399 Jingdong Avenue, Nanchang high tech Industrial Development Zone, Nanchang, Jiangxi Province Patentee after: Jiangxi mansanqi Health Technology Co.,Ltd. Patentee after: INSTITUTE OF APPLIED CHEMISTRY, JIANGXI ACADEMY OF SCIENCES Patentee after: Jiangxi yefengqing Biotechnology Co.,Ltd. Address before: No.7777, Changdong Avenue, high tech Development Zone, Nanchang City, Jiangxi Province, 330000 Patentee before: INSTITUTE OF APPLIED CHEMISTRY, JIANGXI ACADEMY OF SCIENCES Patentee before: Jiangxi yefengqing Biotechnology Co.,Ltd. |
|
| TR01 | Transfer of patent right |